Maypro launches NeuroHD brain health ingredient with RCT support
New York-based Maypro has announced the launch of NeuroHD for neuro-cognitive support. The ingredient is a non-synthetic histidine dipeptide complex derived from a natural source.
Produced by Maypro’s Tokyo-based partner, Tokai Bussan, the ingredient is supported by eight human clinical studies. The human studies show that this complex may help reduce markers of cognitive decline, work to preserve cognitive function, aid brain blood flow, reduce neuro-inflammation, enhance memory, help reduce loss of memory, support a healthy weight, and improve cardiovascular health.
“We are excited to be partnering with Tokai Bussan in offering this science-backed complex to the US market,” said Denis Alimonti, Director of the Proprietary Branded Ingredient Department.